ReviewCancers2025

Continuing Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Advanced Breast Cancer: A Meta-Analysis.

Neha Pathak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.